Key facts
- Distalmotion’s last known valuation is $2.0B (May 2023).
- It has raised $401.5M; the latest was Later Stage VC ($150.0M) in Jan 2026.
- Notable investors include MedTech Innovator, Venture Kick, Kinled Holding, Ecole Polytechnique Federale de Lausanne, Johnson & Johnson JJDC — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Distalmotion
- ·The full record, as it builds
Funding rounds
No funding rounds for Distalmotion are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Distalmotion
Developer of a surgical robotic technology designed to eliminate the complexity of surgical processes. The company's robotic device is used for dissection and suturing and performs a minimally invasive surgical procedure in the abdominal cavity by bridging surgical robotics with laparoscopy, enabling healthcare professionals to offer better healthcare services to their patients.
- Sector
- Healthcare
- HQ
- Lausanne, Switzerland
- Founded
- 2012
- Employees
- 227
- Website
- distalmotion.com/
- Ownership
- Privately Held (backing)
Distalmotion doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Distalmotion shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Distalmotion in its N-PORT filings yet. We sweep new filings monthly.